CDH2 and prostate carcinoma: However, after knocking down miR-3175, cell growth, migration, invasion, and N-cadherin expression, which are related phenotypes, are inhibited, and SCN4B expression is upregulated, suggesting that SCN4B may be a potential mechanism for miR-3175 to promote prostate cancer cell growth and invasion24.